retatrutide 10 pc — 10mg (10 vials) – Peptidic Retatrutide 10MG | Research Peptide
Description
It has not yet received widespread approval for commercial use
We hope that retrospective studies on overdose rates among GLP-1 treated populations will follow
[DOI] [PubMed] [Google Scholar] 104.Wiviott S.D., Raz I., Bonaca M.P., Mosenzon O., Kato E.T., Cahn A., Silverman M.G., Zelniker T.A., Kuder J.F., Murphy S.A., et al
Abbreviations: FDA, Food and Drug Administration
Tirzepatide should not be used during pregnancy and there may be potential risks to an unborn baby from exposure to tirzepatide during pregnancy
